Skip to main content

Overview

Skip to main content

Event Details

Overview

REVEAL-2 Phase 3 Topline Results

May 5, 2026 8:00 AM ET

Webcast (opens in new window)
Presentation (opens in new window)

Quick Links

Viridian Therapeutics
SEC Filings
Events & Presentations
Quarterly Results

IR Contact

IR@viridiantherapeutics.com

Media Contact

Media@viridiantherapeutics.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Viridian Therapeutics, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Viridian Therapeutics, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News

Quarterly Reports

Annual Reports

SEC Filings

End of Day Stock Quote

Events & Presentations

Unsubscribe

Email Alert Sign Up Confirmation

© 2023 Viridian Therapeutics, Inc. - All rights reserved

Powered By Q4 Inc. 5.180.2.5 (opens in new window)

Privacy Policy
Cookie Policy
Terms of Use
Site Map